APMD
APMD
Positions held
Your positionsAPMD isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · Bank of America Puts These 2 Under-the-Radar IPO Stocks on Its Buy List
2026-10-02 · Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-09-22 · Was Moderna Stock's Cancer Vaccine Run Visible In Advance?
2026-09-08 · Apnimed Q2 Swings to Earnings, Revenue Declines
2026-09-08 · Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
2026-09-04 · Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-08-29 · BofA makes bullish call on newly public biotech stock
2026-08-26 · Moderna Stock Carries A Market Value Its Revenue Does Not Support
2026-08-25 · Apnimed shares surge on bullish BofA initiation
2026-08-24 · Moderna Stock Had A Readout Waiting In Plain Sight
2026-08-20 · Moderna's Melanoma Result Landed On A Market Positioned The Other Way
2026-08-14 · Apnimed (APMD) Joins The NASDAQ Composite Index
Price (daily)
Full chart · RSI · MACD · patterns